Eni Wins 2 Blocks Outright in Egypt Oil and Gas Exploration Round

Flames shoot out of a chimney at Petroleum and Natural Gas company factories by a salt lake at the Wadi al-Qamar (Moon Valley) along a highway of Alexandria, Egypt December 6, 2020. (Reuters)
Flames shoot out of a chimney at Petroleum and Natural Gas company factories by a salt lake at the Wadi al-Qamar (Moon Valley) along a highway of Alexandria, Egypt December 6, 2020. (Reuters)
TT
20

Eni Wins 2 Blocks Outright in Egypt Oil and Gas Exploration Round

Flames shoot out of a chimney at Petroleum and Natural Gas company factories by a salt lake at the Wadi al-Qamar (Moon Valley) along a highway of Alexandria, Egypt December 6, 2020. (Reuters)
Flames shoot out of a chimney at Petroleum and Natural Gas company factories by a salt lake at the Wadi al-Qamar (Moon Valley) along a highway of Alexandria, Egypt December 6, 2020. (Reuters)

Italy's Eni was the big winner in an Egyptian auction for oil and gas exploration rights on Tuesday, securing concessions for two of the four blocks outright, according to results from the petroleum ministry.

The company also won a third block with BP and QatarEnergy in the Mediterranean Sea, while Russia's Zarubezhneft was awarded a block in the Nile Delta.

Zarubezhneft's win is a rare expansion abroad by a Russian company since Moscow's full-scale invasion of Ukraine in February 2022.

Zarubezhneft already operates in seven countries, including Egypt where it is a party to production sharing agreements at offshore blocks.

Zarubezhneft declined to comment further.

Egypt, which faces growing demand for gas from its population of 105 million, has been trying to position itself as a regional energy hub, selling its own gas and re-exporting Israeli gas as liquefied natural gas (LNG) to the Middle East, Africa and Europe.

However, the country faced some power cuts in the summer and its natural gas production has fallen to a three-year low.

The government in July announced the start of a $1.8 billion program to drill natural gas exploration wells in the Mediterranean Sea and Nile Delta.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT
20

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.